Detalhe da pesquisa
1.
Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001).
Haematologica
; 107(10): 2295-2303, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35112552
2.
Survival of pediatric Hodgkin lymphoma patients treated with doxorubicin, bleomycin, vincristine, etoposide, prednisone, and cyclophosphamide (ABVE-PC) versus doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) at a single institution.
Pediatr Blood Cancer
; 69(5): e29601, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35187850
3.
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR).
Pediatr Blood Cancer
; 69(11): e29901, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35989458
4.
Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
Pediatr Blood Cancer
; 65(9): e27265, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29797659
5.
ALL and osteonecrosis.
Blood
; 126(15): 1734-5, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26450951
6.
Preexisting or therapy-induced mutations in relapsed acute lymphoblastic leukemia?
Blood
; 136(19): 2233-2235, 2020 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32603411
7.
Oligoclonality and new agent evaluation in acute lymphoblastic leukaemia.
Br J Haematol
; 173(6): 950-7, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27221005
8.
A new standard of care for childhood T-cell acute lymphoblastic leukemia?
Pediatr Blood Cancer
; 68(10): e29238, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34302711
9.
Outcome of Children with Standard-Risk T-Lineage Acute Lymphoblastic Leukemia--Comparison among Different Treatment Strategies.
Pediatr Blood Cancer
; 63(2): 255-61, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26485054
10.
Bortezomib, Dexamethasone, Mitoxantrone, and Vinorelbine (BDMV): An Active Reinduction Regimen for Children With Relapsed Acute Lymphoblastic Leukemia and Asparaginase Intolerance.
J Pediatr Hematol Oncol
; 38(5): 345-9, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27352191
11.
Improving access to novel agents for childhood leukemia.
Cancer
; 121(12): 1927-36, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25678105
12.
Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report.
Cancer
; 121(23): 4205-11, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308766
13.
Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology Group.
Br J Haematol
; 168(4): 533-46, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25308804
14.
Outcomes after induction failure in childhood acute lymphoblastic leukemia.
N Engl J Med
; 366(15): 1371-81, 2012 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22494120
15.
End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T-cell acute lymphoblastic leukemia.
Pediatr Blood Cancer
; 62(11): 2040-3, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25976383
16.
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study.
Blood
; 120(2): 285-90, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22653976
17.
Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group.
Blood
; 117(11): 3010-5, 2011 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21193696
18.
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Blood
; 118(23): 6043-9, 2011 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21967976
19.
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood
; 118(2): 243-51, 2011 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21562038
20.
Remission is good - relapse is bad.
Haematologica
; 103(1): 4-5, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29290629